中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2008年
8期
804-805
,共2页
张孝忠%张晋%张军%王红%原新茹%殷雪萍
張孝忠%張晉%張軍%王紅%原新茹%慇雪萍
장효충%장진%장군%왕홍%원신여%은설평
冠状动脉血运重建%氮氧化钛涂层支架
冠狀動脈血運重建%氮氧化鈦塗層支架
관상동맥혈운중건%담양화태도층지가
Coronary revascularization%Titanium-nitride-oxide-coated stent
目的 探讨氮氧化钛涂层(TTTAN2)支架在经桡/尺动脉途径行冠状动脉血运重建的临床效果.方法入选31例冠心病患者,均采用经桡动脉或尺动脉途径行冠状动脉血运重建.计算TTTAN2支架病变的通过率、早期支架内血栓发生率及随访MACE发生率.结果31例冠状动脉造影发现46处>75%狭窄病变,植入支架45枚,1枚支架未能通过病变,通过率97.8%.植入支架后无残余狭窄、支架脱栽、内膜撕裂、支架内早期血栓形成及冠状动脉破裂.随访1~5个月,无MACE发生.结论TTTAN2支架在冠状动脉血运重建方面临床应用效果良好.
目的 探討氮氧化鈦塗層(TTTAN2)支架在經橈/呎動脈途徑行冠狀動脈血運重建的臨床效果.方法入選31例冠心病患者,均採用經橈動脈或呎動脈途徑行冠狀動脈血運重建.計算TTTAN2支架病變的通過率、早期支架內血栓髮生率及隨訪MACE髮生率.結果31例冠狀動脈造影髮現46處>75%狹窄病變,植入支架45枚,1枚支架未能通過病變,通過率97.8%.植入支架後無殘餘狹窄、支架脫栽、內膜撕裂、支架內早期血栓形成及冠狀動脈破裂.隨訪1~5箇月,無MACE髮生.結論TTTAN2支架在冠狀動脈血運重建方麵臨床應用效果良好.
목적 탐토담양화태도층(TTTAN2)지가재경뇨/척동맥도경행관상동맥혈운중건적림상효과.방법입선31례관심병환자,균채용경뇨동맥혹척동맥도경행관상동맥혈운중건.계산TTTAN2지가병변적통과솔、조기지가내혈전발생솔급수방MACE발생솔.결과31례관상동맥조영발현46처>75%협착병변,식입지가45매,1매지가미능통과병변,통과솔97.8%.식입지가후무잔여협착、지가탈재、내막시렬、지가내조기혈전형성급관상동맥파렬.수방1~5개월,무MACE발생.결론TTTAN2지가재관상동맥혈운중건방면림상응용효과량호.
Objective To evaluate the efficacy of trans-ulner or trans-radial approach to coronary revaseularization with titanium-nitride-oxide-eoated stent (TITAN2). Methods 31 patients,who were planed to receive coronary revaseularization,were selected into this study. All patients with coronary revascularization were either by trans-ulner or by trans-radial approach. The pass-through rate of stent, early thrombosis in stent and MACE at followup were recorded for TITAN2. Results 46 lesions with stenosis > 75% with coronary angiograpby in 31 patients successfully underwent coronary revaseularization with TITAN2. One stent didn't go through the lesion in RCA. The pass-through rate of stent was 97.8%. Remaining stenesis ,stent unglues,endarterium laceration ,early thrombosis in stent and coronary rupture were not discovered after stent deployment. MACE was 0 at 1-5 month follow-up. Conclusion Confirmed good efficacy in coronary revascularization with TITAN2 is observed.